The Legal 500

United States > Litigation > Mass tort and class action: plaintiff representation - pharmaceuticals and medical devices

Share this page

Editorial

Index of tables

  1. Mass tort and class action: plaintiff representation - pharmaceuticals and medical devices
  2. Leading lawyers

Leading lawyers

  1. 1

Burg Simpson Eldredge Hersh & Jardine, P.C. maintains an enviable reputation in the class action space and continues to be at the forefront of pharmaceutical and hip implant litigation. Few teams are able to match its quality of resources, with multiple attorneys occupying leadership positions in mass tort cases. It has continued to play a leading role in the Yaz/Yasmin litigation, with team members serving as co-counsel and, separately, chairing MDL committees. In 2014 Seth Katz, who is based in the firm’s Denver office, was appointed to serve both on the plaintiffs’ executive committee and as co-chair of the discovery committee in In re: Testosterone Replacement Therapy Products Liability Litigation in the Northern District of Illinois. The team continues to be active in the Actos litigation; the plaintiffs allege a link between Actos and developing bladder cancer. Michael Burg and Peter Burg, who are based in the firm’s Denver office, and Cincinnati-based Janet Abaray are other standout names in the team.

Herman, Herman & Katz LLC enjoys an excellent standing in this area and is well-known for its appointment to leadership positions and its expertise in electronic discovery. Team members served on the plaintiffs’ discovery and pleadings subcommittee and plaintiffs’ executive committee in a claim, recently settled, against Teva that alleged defects with the drug Budeprion. It is currently involved in the high-profile NFL concussion litigation initiated by former players against multiple defendants; of counsel Joseph Kott serves on the plaintiffs’ science and medical committee. The New Orleans-based firm remains committed to developing new cases and is currently representing plaintiffs in pending MDL proceedings for the alleged injuries caused by the blood-thinner Xarelto. Stephen Herman is valued for his ‘strategic thinking and leadership skills’ and Russ Herman is recommended for his ‘trial skills’. Soren Gisleson, Leonard Davis, Maury Herman and James Klick are also highly regarded.

Levin Papantonio Thomas Mitchell Rafferty & Proctor, P.A.’s team consists almost entirely of trial lawyers and the firm continues to excel in preparing cases for trial and participating in bellwether trials. The Florida-based team was particularly influential in the Yaz/Yasmin litigation; team members served on the plaintiffs’ steering committee, co-chaired the discovery committee and were part of the bellwether trial team. It is currently preparing for trial in both the trans-vaginal mesh and metal-on-metal hip replacement cases. In 2014 the firm negotiated a $27.7m settlement with Merck & Co on behalf of plaintiffs who allegedly suffered jaw injuries after taking Fosamax. The firm’s strong standing in conducting depositions was reinforced through its involvement in the Pradaxa litigation, with team members travelling to Europe to interview witnesses. Mike Papantonio heads the practice, Troy Rafferty is a key name on mass torts, Fredric Levin is noted for his trial expertise and Timothy O’Brien is also recommended.

Lieff Cabraser Heimann & Bernstein, LLP continues to be involved in defective hip litigation and is representing clients in MDL and Judicial Council Coordinated Proceedings (JCCP). The firm is involved in settlement negotiations for DePuy’s ASR hip implants and is preparing for bellwether trials alleging that DePuy’s Pinnacle artificial hips prematurely failed. It continues to play a leading role in the Actos litigation, and Donald Arbitblit was part of the trial team that secured an award of $9bn in punitive damages following a case in Louisiana in 2014; the firm is currently preparing to serve as lead counsel in the first Actos case to be tried in California. Elizabeth Cabraser and Robert Nelson, along with Arbitblit, are key names in the San Francisco office and Wendy Fleishman is a strong presence in New York.

The Lanier Law Firm has an excellent reputation for its courtroom ability and is led by renowned trial lawyer W Mark Lanier. Name partner Lanier led the trial team in securing a $9bn verdict on behalf of plaintiffs who alleged there was a link between bladder cancer and diabetes drug Actos. The firm continues to be involved in litigation concerning DePuy’s artificial hip implants and represents plaintiffs both nationally and overseas. Robert Leone, who is dual-qualified as a psychologist, is well known for his pre-trial jury analysis and Alex Brown and Los Angeles-based Lee Cirsch are also recommended. All attorneys, except where stated otherwise, are based in the firm’s Houston office.

Philadelphia-based firm Levin, Fishbein, Sedran & Berman continues to take on leadership positions in high-profile litigation and has an array of discovery experience. It has been appointed to serve on the executive committee, the Daubert committee and several sub-committees in the GranuFlo litigation currently pending in the federal court of Massachusetts. The firm continues its involvement in the long-running diet drug litigation and is actively assisting the settlement trust. Arnold Levin, Frederick Longer, Laurence Berman, Michael Fishbein and Michael Weinkowitz are key names in the team.

Seeger Weiss LLP enjoys an excellent reputation in this area and serves clients from its offices in New York, New Jersey and Pennsylvania. Co-founder Christopher Seeger, who is based in the firm’s New York office, was influential in the NFL concussion litigation, serving as co-lead counsel and chief negotiator; the litigation resulted in the establishment of funds providing for a comprehensive medical exam for former players and compensation for retired players who have suffered cognitive impairment. New Jersey-based David Buchanan continues to hold positions on a variety of discovery, expert and executive committees.

Ashcraft & Gerel LLP’s team operates from its offices in Washington DC, Virginia and Maryland. It has continued to represent plaintiffs in litigation concerning Tylenol, Yaz/ Yasmin and DePuy’s ASR and Pinnacle hip implants. Michelle Parfitt, who is experienced in preparing expert testimony, and James Green, who has served on MDL committees for litigation including Fosamax and Rezulin, are recommended. All attorneys named are based in the firm’s Washington DC office.

Beasley, Allen, Crow, Methvin, Portis & Miles, P.C. represents clients from its single site office in Montgomery, Alabama. Frank Woodson continues to be involved in both the GranuFlo and shoulder pump litigation, Matthew Teague is active in the testosterone replacement therapy litigation and P Leigh O’Dell is leading the firm’s representation in the Gardasil litigation. Andy Birchfield heads the firm’s mass tort practice.

Client Intelligence Report

The Legal 500 United States - Events

GC Magazine -
Summer 2015

GC Powerlist -
United States

Press releases

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • 27 April 2016: Greatbatch/INTEGER

    Following completion of the acquisition of the Lake Region Medical groupe by Greatbatch, Inc. and the renaming of Lake Region Medical into INTEGER, Greatbatch contributed in multiple capital increases own shares to Swiss-based P Medical Holding AG/INTEGER (Switzerland) GmbH, which were swapped against shares in the Irish-based Lake Region Medical Holdings Limited. The transaction was completed by a down-stream merger of P Medical Holding AG into its subsidiary INTEGER (Switzerland) GmbH.
  • Liability Management Exercise of International Container Terminal Services, Inc. and affiliates

    SyCipLaw acted as Philippine counsel for the dealers, Citigroup Global Markets Limited and Hong Kong and Shanghai Banking Corporation in a back-to-back tender offer of perpetual securities and issuance of new perpetual securities.
  • New China Customs Taxation Policy on Cross-Border B2C E-Commerce Imports

    The Ministry of Finance, General Administration of Customs and State Administration of Taxation of China jointly issued a circular (“Joint Circular ”) relating to the taxation policy on the cross-border e-commerce retailing imports, with effect as from April 8, 2016.
  • Philippine Competition Commission Issues Transitory Rules for Mergers and Acquisition

    On February 12, 2016, the recently constituted Philippine Competition Commission (“PCC”), which was created under the Philippine Competition Act (Republic Act 10667 or the “PCA”), issued Memorandum Circular No. 16-001, Series of 2016 (the “Transitory Rules”), which provides for the transitory rules and guidelines relating to mergers and acquisitions that were, or are to be, executed or otherwise implemented after the effectivity of the PCA on August 8, 2015 but before the effectivity of its implementing rules and regulations (the “PCA IRR”). Given the special nature of transactions effected through the Philippine Stock Exchange, the Transitory Rules will not cover such transactions and will be covered by a separate issuance by the PCC.
  • Financing for the Mactan Cebu International Airport

    SyCipLaw acted as Philippine counsel to a syndicate of Philippine banks (composed of BDO Unibank, Inc., Bank of the Philippine Islands, Development Bank of the Philippines, Land Bank of the Philippines, Metropolitan Bank & Trust Company and Philippine National Bank) and Asian Development Bank for the financing of the rehabilitation and development of the Mactan Cebu International Airport that was awarded by the DOTC and the MCIAA under the private-public partnership program of the government to the consortium between Megawide Construction Corporation and GMR Infrastructure. The financing is composed of (1) Php20 Billion (approx. US$446,773,200) commitment of the Philippines syndicate banks and (2) US$75 Million commitment of ADB.
  • Philippine Competition Commission Issues Transitory Rules on PSE-related Mergers and Acquisitions

    On February 16, 2016, the recently constituted Philippine Competition Commission (“PCC”), which was created under the Philippine Competition Act (Republic Act 10667 or the “PCA”), issued Memorandum Circular No. 16-002, Series of 2016 (the “PSE Transitory Rules”), which provides for the transitory rules and guidelines relating to mergers and acquisitions that were, or are to be, executed or otherwise implemented through the Philippine Stock Exchange (“PSE”) and after the effectivity of the PCA on August 8, 2015 but before the effectivity of its implementing rules and regulations (the “PCA IRR”).
  • 2016: Insurance regulation in Asia Pacific – Ten things to know about 20 countries

    SyCipLaw contributed the Philippine Chapter of the 2016: Insurance Regulation in Asia Pacific – Ten things to know about 20 countries published by Norton Rose. The 2016 edition of the summary guide provides an overview and practical checklist of ten common regulatory issues for insurance companies. The Philippine chapter was contributed by SyCipLaw partner Hiyasmin H. Lapitan.
  • Predictive Coding Software in the E-Disclosure Process Approved by English Court

    In the recent case of Pyrrho Investments Limited and another v MWB Property Limited and others [2016] EWHC 256 (Ch), the High Court of England and Wales approved the use of predictive coding software in electronic discovery.
  • Enabling the Business of Agriculture 2016

    SyCipLaw Partners Rose Marie M. King-Dominguez and Franco Aristotle G. Larcina, with support from Senior Associate Ruben P. Acebedo II, participated in the World Bank Group’s Enabling the Business of Agriculture 2016: Comparing regulatory good practices. The report examines regulations that impact private enterprise in the agriculture and agribusiness sectors. The report aims to promote smart regulations that ensure safety and quality control, as well as efficient regulatory processes, that support thriving agribusinesses.
  • April 2016: Mövenpick invests in imported wine wholesaler Cheers in China

    Hospitality and food service industry company Mövenpick invests in Chinese wine wholesaler Cheers by acquiring a strategic stake. Cheers has 30 branch offices in the greater Beijing area and currently generates annual revenues of roughly three million Swiss francs. Mövenpick is a Swiss group of companies with global presence. Its core competency lies in the hospitality business, with a focus on gastronomy, hotels, wine and premium branded products.

Press Releases worldwide

The latest news direct from law firms. If you would like to submit press releases for your firm, send an email request to